Team perfects non-lethal way of switching off essential genes in mice

April 14, 2011 in Genetics
CSHL team perfects non-lethal way of switching off essential genes in mice

Enlarge

In contrast to intestinal cells in normal mice (top), cells in mice in which the RPA3 gene has been shut down by an shRNA fail to proliferate, causing the tissue to atrophy (bottom). Credit: Scott Lowe@CSHL

One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will kill the organism before the gene's function can be determined. Researchers at Cold Spring Harbor Laboratory (CSHL) have overcome this problem by using RNA interference (RNAi) technology to temporarily turn off any essential gene in adult mice and then turn it back on before the change kills the animals.

In a study published online on April 12 in the journal , the scientists demonstrated the feasibility of this approach by turning off a gene necessary for in mice until the animals lost weight and were at the brink of death, and then successfully reversing these symptoms and rescuing the mice by turning the gene back on.

The ability to regulate this way in animals "will not only help in pinpointing timeframes during which essential genes are important during development, but will also be tremendously useful in cancer or other disease-related research," says CSHL Professor and HHMI investigator Scott Lowe, Ph.D., who co-led the team along with Professor Bruce Stillman, Ph.D., CSHL's president. "We could, for example, first allow tumors to grow in mice, then shut off a gene that we think might be a good to test whether it saves the animals," Lowe explains.

To suppress gene activity with RNAi, scientists have been using short hairpin-shaped RNA (shRNA) molecules that attach to matching pieces of the target gene's RNA and trigger its destruction, thereby shutting down the production of protein from that gene. Having refined and optimized the process of using these shRNA to knock down gene activity in mice over the last few years, Lowe and collaborators including CSHL Professor and HHMI investigator Gregory Hannon, Ph.D., came up with a technology platform, recently published in the journal Cell, that allows them to create genetically modified, or transgenic, mice within 4 months, which is three times faster than standard approaches.

The current study was designed to test whether this new optimized system was robust enough to allow efficient targeting of essential . To find the right gene to target, the team first screened an RNAi "library," or a large collection of shRNAs, to select only molecules that block cell proliferation by shutting off a particular gene. This screening experiment yielded shRNAs against one part—subunit 3—of replication protein A (RPA3), a protein complex discovered in Stillman's lab in the late 1980s that promotes DNA replication by stabilizing unwinding DNA strands and recruiting other necessary proteins.

The shRNAs that targeted RPA3 were linked to a fluorescent tag. These were then used to generate transgenic mice in such a way that the team could trigger RNAi and shut off the RPA3 gene when the animals were fed a drug like tetracycline but not when the drug was withdrawn. The fluorescent tag allowed the scientists to easily monitor the tissues in which the target RPA3 gene had been switched off.

When the scientists induced RPA3 suppression in adult mice, the animals' intestinal tissues rapidly atrophied and the mice lost weight and died within 8-11 days. But if the researchers withdrew the drug when the mice were almost at the point of death, both atrophy and weight loss were fully reversed and the mice survived. While the authors plan to further study these mice to understand mechanisms of tissue maintenance and regeneration, they are also excited by the broader implications of their new approach.

"This ability to toggle gene activity at any stage is a major advance over other gene knockdown techniques that are not reversible," says Stillman. "This approach in animal models is the closest genetic equivalent to treating human patients with a single dose of a small molecule-based therapy targeted at a particular gene. So this system will be invaluable for testing novel therapeutic targets and evaluating their efficacy and side-effects."

More information: "Reversible suppression of an essential gene in adult mice using transgenic RNA interference," appears in online early edition issue of the Proceedings of the National Academy of Sciences in the week of April 11. The full citation is: Katherine McJunkin, Anthony Mazurek, Prem K. Premsrirut, Johannes Zuber, Lukas E. Dow, Janelle Simon, Bruce Stillman, and Scott W. Lowe. The paper can be downloaded at http://www.pnas.or … ull.pdf+html

Provided by Cold Spring Harbor Laboratory search and more info website

5 /5 (3 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

CSharpner
Apr 14, 2011

Rank: not rated yet
They can already switch specific genes on and off, throughout the ENTIRE organism ?!?!? Without having to make the change in a fertilized egg (one cell) and grow a new organism with the change? Holy Crap! I thought we were still DECADES, if not, then CENTURIES away from this! This is Star Trek technology!

I'm floored! And impressed! And amazed!
moj85
Apr 14, 2011

Rank: not rated yet
To be fair, they can only switch those genes that have been turned 'off' by the shRNA back to 'on'. They cannot constitutively increase the expression of genes with shRNA
Jeffhans1
Apr 14, 2011

Rank: not rated yet
I am as impressed as you. This should result in cures for multiple genetic diseases.
pauljpease
Apr 14, 2011

Rank: not rated yet
No, they still need 4 months to genetically engineer the mice to produce the correct shRNA. But once they do that, they can turn the gene off and on by feeding the mouse a drug, controlling expression of the shRNA
PPihkala
Apr 22, 2011

Rank: not rated yet
Others are more able to do this without prior tissue engineering:
http://www.physor...apy.html
Rank 5 /5 (3 votes)
Relevant PhysicsForums posts

More news stories

Researchers unravel the relation between DNA methylomes and obesity

In a highlighted paper published online in Nature Communications, researchers from Sichuan Agricultural University and BGI reported the atlas of DNA methylomes in porcine adipose and muscle tissues, providing a valuable epigen ...

Genetics created 2 hours ago | popularity not rated yet | comments 0

Elimination of two ribosome subunits activates cell cycle control

Alterations in the formation of ribosomes (the elements of the cell where proteins are made) cause the induction of p53 protein and cell cycle disruption. This process is crucial to understand fundamental biological processes ...

Genetics created 4 hours ago | popularity not rated yet | comments 0

Distinct molecular subtype of prostate cancer identified

A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical ...

Genetics created May 20, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Gene mapping reveals architecture that controls expression of genes responsible for our sense of smell

Within the nasal cavity, millions of sensory neurons in a postage-stamp-sized patch of tissue called the olfactory epithelium control our sense of smell. Thanks to the exquisitely controlled expression of ...

Genetics created May 18, 2012 | popularity 5 / 5 (1) | comments 1

'Rare' genetic variants are surprisingly common, life scientists report

(Medical Xpress) -- A large survey of human genetic variation, published today in the online version of the journal Science, shows that rare genetic variants are not so rare after all and offers insights into h ...

Genetics created May 18, 2012 | popularity 5 / 5 (4) | comments 0 | with audio podcast


Body building, diet supplements linked to liver damage: study

(HealthDay) -- Body-building and weight-loss products are the types of dietary supplements most likely to cause liver injury, according to a small new study.

Limits to growth: Scientists identify key metastasis-enabling enzyme

(Medical Xpress) -- On the complex road to eradicating cancer, controlling or preventing metastatic growth initiated by primary tumors is high on the to-do list. A key area of such research is the development ...

Do bald men face higher risk of prostate cancer?

(HealthDay) -- Got hair? If you don't, you might have a higher risk of prostate cancer, a preliminary study suggests.

Asthma medication linked with arrhythmias in children, young adults

Use of inhaled anticholinergics (IACs) has been associated with an increased risk of potentially dangerous heart arrhythmias among young asthma patients, according to a study conducted by researchers at the University of ...

U.S. liver transplants declining

(HealthDay) -- The number of liver transplants in the United States has decreased since 2006, a new study finds.

Neuron-nourishing cells appear to retaliate in Alzheimer's

When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers ...